Stock Price Forecast

March 27, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Ocuphire Pharma Inc chart...

About the Company

ocuphire is a new biopharmaceuticals company focused on developing and commercializing small molecule drugs for unmet medical needs in the ocular disease space. ocuphire’s lead drug candidate, nyxol eye drops, is aimed to treat patients with night vision disturbances (nvd), glaucoma and presbyopia (impaired near-term vision). ocuphire is in discussions with a prospective late stage ophthalmic drug program that could be developed in parallel. ocuphire's management team has over 100 years of drug development expertise across a diverse set of therapeutic areas including ophthalmology, orphan, cardio-metabolic, nephrology, oncology and respiratory.

CEO

Douglas Swirsky

Exchange

NASDAQ

Website

https://www.rexahn.com/

$36M

Total Revenue

14

Employees

$48M

Market Capitalization

3.50

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $OCUP News

Earnings Update: Ocuphire Pharma, Inc. (NASDAQ:OCUP) Just Reported And Analysts Are Trimming Their Forecasts

15d ago, source:

Ocuphire Pharma, Inc. ( NASDAQ:OCUP ) just released its latest yearly report and things are not looking great. It ...

Design Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying

on MSN ago, source:

The Dow Jones index closed lower by over 150 points on Monday. When insiders purchase or sell shares, it indicates their ...

Compare with SCHOTT Pharma AG & Co KgaA (STTPF)

7d ago, source: Hosted on MSN

Select "Add to Compare" to begin comparing Stocks, ETFs, Mutual Funds and more.

Why Ebonyi is choice destination for Pharma Park project – Pharmacists

8d ago, source: The Punch on MSN

Nigerian Association of Industrial Pharmacists has said its choice of Ebonyi State for the establishment of Salt City Pharma Park was hinged on the availability of needed infrastructure and the ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...